Dr. McCulloch is a co-founder of Insilicomed Inc., an exclusive licensee from UCSD of Continuity 6.3 for commercial applications in biomedical research, diagnostics and therapeutics. This relationship is disclosed to the UCSD Internal Review Committee (IRC) and is overseen by a Conflict of Interest Management Sub-Committee appointed by the IRC.